Drug-protein binding: a critical review of analytical tools.
about
Colloquium : 100 years of mass spectrometry: Perspectives and future trendsKinetic analysis of drug-protein interactions by affinity chromatographyHigh-throughput 1,536-well fluorescence polarization assays for α(1)-acid glycoprotein and human serum albumin bindingMass spectrometry quantifies protein interactions--from molecular chaperones to membrane porins.Hydrogen-deuterium exchange mass spectrometry for determining protein structural changes in drug discovery.Localizing Carbohydrate Binding Sites in Proteins Using Hydrogen/Deuterium Exchange Mass Spectrometry.Studies of metabolite-protein interactions: a reviewScreening a fragment cocktail library using ultrafiltration.Recent application of analytical methods to phase I and phase II drugs development: a review.Unraveling the mysteries of serum albumin-more than just a serum protein.Cellular membrane phospholipids act as a depository for quaternary amine containing drugs thus competing with the acetylcholine/nicotinic receptor.Connecting simulated, bioanalytical, and molecular docking data on the stereoselective binding of (±)-catechin to human serum albumin.Applications of isothermal titration calorimetry in pure and applied research--survey of the literature from 2010.Affinity capillary electrophoresis: the theory of electromigration.The bioanalytical challenge of determining unbound concentration and protein binding for drugs.A fluorescence-based high throughput assay for the determination of small molecule-human serum albumin protein binding.Photoactive assemblies of organic compounds and biomolecules: drug-protein supramolecular systems.The application of capillary electrophoresis techniques in toxicological analysis.Characterization of interactions between methoxatin disodium salt and human serum albumin by pressure-assisted capillary electrophoresis/frontal analysis and circular dichroism spectroscopy.Effect of a Pluronic(®) P123 formulation on the nitric oxide-generating drug JS-K.Differential radial capillary action of ligand assay for high-throughput detection of protein-metabolite interactionsInteraction between the Natural Components in Danhong Injection (DHI) with Serum Albumin (SA) and the Influence of the Coexisting Multi-Components on the SaB-BSA Binding System: Fluorescence and Molecular Docking Studies.Potentiating the cellular targeting and anti-tumor activity of Dp44mT via binding to human serum albumin: two saturable mechanisms of Dp44mT uptake by cells.Screening of the binding properties of molecularly imprinted nanoparticles via capillary electrophoresis.Characterization of plasma protein binding dissociation with online SPE-HPLC.Investigating metabolite-protein interactions: an overview of available techniques.Fatty acid DSF binds and allosterically activates histidine kinase RpfC of phytopathogenic bacterium Xanthomonas campestris pv. campestris to regulate quorum-sensing and virulence.Inhibition of cell adhesion and immune responses in the mouse model of collagen-induced arthritis with a peptidomimetic that blocks CD2-CD58 interface interactions.Analysis of free drug fractions in serum by ultrafast affinity extraction and two-dimensional affinity chromatography using α1-acid glycoprotein microcolumns.Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering.Analysis of free drug fractions in human serum by ultrafast affinity extraction and two-dimensional affinity chromatography.Mass spectrometry-based monitoring of millisecond protein-ligand binding dynamics using an automated microfluidic platformStereoselective binding of chiral drugs to plasma proteinsProtein purification-free method of binding affinity determination by microscale thermophoresis.A simple model-free method for direct assessment of fluorescent ligand binding by linear spectral summation.Plasma protein binding and blood-free concentrations: which studies are needed to develop a drug?Monitoring free drug concentrations: challenges.Recent developments in CE and CEC of peptides (2009-2011).Mass spectrometry based tools to investigate protein-ligand interactions for drug discovery.On the binding affinity of macromolecular interactions: daring to ask why proteins interact.
P2860
Q21563835-5F0F3B73-99F0-41DA-B4A9-3737D63CD220Q28069746-CBCDEC20-7E0D-4A26-A8C5-32C2B9568ACEQ28483928-7C1D5926-2D9F-4D19-9EB8-B7D008056C23Q30368236-97CA4D72-6386-457D-81FC-526E1D10EDEAQ30372448-0986514B-EA6D-4A5D-9A77-98C215D1FE98Q30379769-3FD98BAA-62A9-476C-9621-2BB8C376CD77Q33657421-48CA7D5A-91AB-46C0-9EDF-851CAC568136Q33959477-51EC3433-684A-48A9-A05E-374CC376553EQ33997398-58B3D557-EE3F-4903-B1DB-4B74EA1EA9F1Q34030577-364E1F54-816F-4F22-85C5-1C63F53533C7Q34086865-ABB97B00-3148-4388-A512-03FF2142C104Q34112418-754F6E5C-859C-40C3-9B89-0494D77AA9F6Q34244067-200CC915-935D-40DF-B12E-03C6A5954C61Q34538402-B2101653-CB0E-4EA9-B473-4EED5BD75F20Q35062663-7ACFAE4D-8A36-48D6-B438-82345A9FCC3EQ35081931-D67B8D70-7BD3-4B1D-A0F6-6003D2BB1902Q35123150-1840179C-BA4A-4421-9B94-DD88DDF41A1BQ35168632-6078776B-E98C-426A-AFAF-F70977F73537Q35172118-EC2B1DE9-F815-4D2A-A240-56A39E23188FQ35175551-D34C9383-1B4A-4AFA-8647-CC1A1AA86DB3Q35216869-59FFF135-FF43-4199-BCFC-649BE40468FBQ35649957-197E6CE9-7E9F-457F-ACB4-F89CB116CA2DQ35833012-109E6197-EDB5-4605-885E-F63B1833A6DFQ35951613-8FCF909C-E382-4860-8348-9D44236C7E90Q36149937-FBF26C0C-1F0A-4D19-AD90-8B5131095754Q36252541-84A292A5-347C-4935-8347-EDB9B738B850Q36331978-8328FA7E-1EBD-4747-82D7-0CB48FBADEE9Q36338863-17D7E583-BE6B-470B-A43E-4AC1B6E62CCCQ36494517-7827C8B1-AF3D-4CE0-B65D-05859C9C6A88Q36590092-CD1C5E77-75CD-44A0-8766-B798F361DD39Q36619568-CA5040C1-C48C-4CDB-8507-97A429BE77F9Q36840082-510E879A-1242-4896-B70E-2D0912449D98Q37069257-74679E2B-9D5D-427C-9041-A67031C49F1EQ37356284-058C8221-BDFE-4127-A820-DF2F482670CAQ37622057-C4DA9590-7199-49FD-95C8-74607350DAC8Q37884058-11DD83A6-EA45-4D0D-9BB4-0DC3FFE2612BQ37914158-CA077FF3-4075-4C67-9476-9C644C919A44Q37964561-23C64EE1-BA48-4F43-8E80-33146FE77DFDQ38005330-720726A0-3002-4D8A-92AB-E0F895F5C424Q38067023-1E7E4E42-6ABA-407A-AFB5-39C71A28EC15
P2860
Drug-protein binding: a critical review of analytical tools.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug-protein binding: a critical review of analytical tools.
@en
Drug-protein binding: a critical review of analytical tools.
@nl
type
label
Drug-protein binding: a critical review of analytical tools.
@en
Drug-protein binding: a critical review of analytical tools.
@nl
prefLabel
Drug-protein binding: a critical review of analytical tools.
@en
Drug-protein binding: a critical review of analytical tools.
@nl
P2093
P1476
Drug-protein binding: a critical review of analytical tools.
@en
P2093
Jean-Luc Veuthey
Julie Schappler
Karine Vuignier
Sophie Martel
P2888
P356
10.1007/S00216-010-3737-1
P407
P577
2010-05-09T00:00:00Z